Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting
DOI:
https://doi.org/10.5055/jom.2016.0333Keywords:
opioid misuse, adolescents, young adults, cancerAbstract
Prescription opioid use has increased in recent decades. Although opioids provide effective pain control, their use may be associated with the risk of misuse. Opioid misuse (OM) is prevalent among adolescents and young adults (AYAs). Opioids are necessary to treat cancer-related pain; however, oncology patients are not immune to medication misuse. Research examining OM among AYAs with cancer is scarce. This article examines the risk factors described in the general adult and adolescent medication abuse literature and aims to provide recommendations for practice in the AYA oncology population. The following risk factors should be examined in AYA oncology patients to determine their relevance: age, sex, behavioral and academic problems, psychological conditions, and a history of illicit drug use/abuse. To maintain the delicate balance of providing adequate pain relief while protecting patients from the risk of OM, clinicians must consider potential risk factors, motivating factors, and individual behaviors. Placing these challenges in perspective, this review provides clinical considerations, recommendations, and intervention strategies for OM prevention in AYA oncology patients.
References
Fortuna RJ, Robbins BW, Caiola E, et al.: Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010; 126(6): 1108-1116.
DeVries A, Koch T, Wall E, et al.: Opioid use among adolescent patients treated for headache. J Adolesc Health. 2014; 55(1): 128-133.
Richardson LP, Fan MY, McCarty CA, et al.: Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry. 2011; 33(5): 423-428.
Mazer-Amirshahi M, Mullins PM, Rasooly IR, et al.: Trends in prescription opioid use in pediatric emergency department patients. Pediatr Emerg Care. 2014; 30(4): 230-235.
Anghelescu DL, Ehrentraut JH, Faughnan LG: Opioid misuse and abuse: Risk assessment and management in patients with cancer pain. J Natl Compr Canc Netw. 2013; 11(8): 1023-1031.
Crofford LJ: Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010; 6(4): 191-197.
Edwards RR, Wasan AD, Michna E, et al.: Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain. 2011; 12(9): 953-963.
Jamison RN, Link CL, Marceau LD: Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med. 2009; 10(6): 1084-1094.
Jamison RN, Ross EL, Michna E, et al.: Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial. Pain. 2010; 150(3): 390-400.
Passik SD, Portenoy RK, Ricketts PL: Substance abuse issues in cancer patients. Oncology. 1998; 12(4): 517-521.
Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24(6): 497-508.
Zosel A, Bartelson BB, Bailey E, et al.: Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System. J Am Acad Child Adolesc Psychiatry. 2013; 52(2): 196-204.
Paulozzi LJ: Prescription drug overdoses: A review. J Safety Res. 2012; 43(4): 283-289.
Boyd CJ, Esteban McCabe S, Teter CJ: Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug Alcohol Depend. 2006; 81(1): 37-45.
Birnbaum HG, White AG, Schiller M, et al.: Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011; 12(4): 657-667.
Cicero TJ, Wong G, Tian Y, et al.: Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database. Pain. 2009; 144(1-2): 20-27.
White AG, Birnbaum HG, Mareva MN, et al.: Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005; 11(6): 469-479.
Substance Abuse and Mental Health Services Administration: Attitudes about mental illness and its treatment: Validation of a generic scale for public health surveillance of mental illness associated stigma. Community Ment Health J. 2010; 46(2): 164-176.
Substance Abuse and Mental Health Services Administration: Results From the 2008 National Survey on Drug Use and Health. National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2009.
McCabe SE, Boyd CJ, Young A: Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2007; 40(1): 76-83.
Wu L-T, Pilowsky DJ, Patkar AA: Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend. 2008; 94(1-3): 1-11.
Meier EA, Troost JP, Anthony JC: Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: National estimates by age and by year. Arch Pediatr Adolesc Med. 2012; 166(9): 803-807.
Bleyer A, O’Leary M, Barr R, et al. (eds.):. Cancer Epidemiology in Older Adolescents and Young Adults 15-29 Years of Age, Including SEER Incidence and Survival: 1975- 2000. Bethesda, MD: National Cancer Institute, 2006.
Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2): 83-103.
Ballantyne JC: Opioid misuse in oncology pain patients. Curr Pain Headache Rep. 2007; 11(4): 276-282.
Ries LAG, Melbert D, Krapcho M, et al. (eds): Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute, 2007.
Ljungman G, Gordh T, Sörensen S, et al.: Pain variations during cancer treatment in children: A descriptive survey. Pediatr Hematol Oncol. 2000; 17(3): 211-221.
Miser AW, Dothage JA, Wesley RA, et al.: The prevalence of pain in a pediatric and young adult cancer population. Pain. 1987; 29(1): 73-83.
Patt RB, Burton AW: Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. In Aronoff GM (ed.): Evaluation and Treatment of Chronic Pain. New York, NY: Williams & Wilkins, 1998: 337-376.
World Health Organization: Cancer Pain Relief, With a Guide to Opioid Availability. 2nd ed. Geneva: World Health Organization, 1996.
Ehrentraut JH, Kern KD, Long SA, et al.: Opioid misuse behaviors in adolescents and young adults in a hematology/ oncology setting. J Pediatr Psychol. 2014; 39(10): 1149-1160.
Hojsted J, Sjogren P: Addiction to opioids in chronic pain patients: A literature review. Eur J Pain. 2007; 11(5): 490-518.
Martell BA, O’Connor PG, Kerns RD, et al.: Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med. 2007; 146(2): 116-127.
Cowan DT, Wilson-Barnett J, Griffiths P, et al.: A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2003; 4(4): 340-351.
Fishbain DA, Rosomoff HL, Rosomoff RS: Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992; 8(2): 77-85.
Ives TJ, Chelminski PR, Hammett-Stabler CA, et al.: Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006; 6: 46.
Michna E, Ross EL, Hynes WL, et al.: Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage. 2004; 28(3): 250-258.
Schepis TS, Krishnan-Sarin S: Characterizing adolescent prescription misusers: A population-based study. J Am Acad Child Adolesc Psychiatry. 2008; 47(7): 745-754.
McCabe SE, Boyd CJ, Teter CJ: Illicit use of opioid analgesics by high school seniors. J Subst Abuse Treat. 2005; 28(3): 225-230.
Nelson EC, Heath AC, Lynskey MT, et al.: Childhood sexual abuse and risks for licit and illicit drug-related outcomes: A twin study. Psychol Med. 2006; 36(10): 1473-1483.
Martins SS, Keyes KM, Storr CL, et al.: Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009; 103(1-2): 16- 24.
Edlund MJ, Steffick D, Hudson T, et al.: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007; 129(3): 355-362.
Pedersen W, Lavik NJ: Adolescents and benzodiazepines: Prescribed use, self-medication and intoxication. Acta Psychiatr Scand. 1991; 84(1): 94-98.
Edlund MJ, Martin BC, Russo JE, et al.: The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: The role of opioid prescription. Clin J Pain. 2014; 30(7): 557-564.
White AG, Birnbaum HG, Schiller M, et al.: Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009; 15(12): 897-906.
Boscarino JA, Rukstalis M, Hoffman SN, et al.: Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010; 105(10): 1776-1782.
Palmer RE, Carrell DS, Cronkite D, et al.: The prevalence of problem opioid use in patients receiving chronic opioid therapy: Computer-assisted review of electronic health record clinical notes. Pain. 2015; 156(7): 1208-1214.
Rice JB, White AG, Birnbaum HG, et al.: A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012; 13(9): 1162-1173.
Miech R, Johnston L, O’Malley PM, et al.: Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015; 136(5): e1169-e1177.
Chabal C, Erjavec MK, Jacobson L, et al.: Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain. 1997; 13(2): 150-155.
Kahan M, Srivastava A, Wilson L, et al.: Misuse of and dependence on opioids: Study of chronic pain patients. Can Fam Physician. 2006; 52(9): 1081-1087.
Zale EL, Dorfman ML, Hooten WM, et al.: Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: Results from a nationally representative sample. Nicotine Tob Res. 2015; 17(9): 1096-1103.
Potter JS, Hennessy G, Borrow JA, et al.: Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend. 2004; 76(2): 213-215.
Dunbar SA, Katz NP: Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage. 1996; 11(3): 163-171.
Schieffer BM, Pham Q, Labus J, et al.: Pain medication beliefs and medication misuse in chronic pain. J Pain. 2005; 6(9): 620-629.
Sung H-E, Richter L, Vaughan R, et al.: Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. J Adolesc Health. 2005; 37(1): 44-51.
Elhammady M, Awara M, Aty AA, et al.: Self-reported child sexual abuse, physical abuse, and parental history of drug misuse in opioid dependence syndrome. Addict Disord Their Treat. 2014; 13(4): 151-158.
Charles N, Ryan S, Acheson A, et al.: Childhood stress exposure among preadolescents with and without family histories of substance use disorders. Psychol Addict Behav. 2015; 29(1): 192-200.
Rudolph K, Hammen C: Age and gender as determinants of stress exposure, generation, and reactions in youngsters: A transactional perspective. Child Dev. 1999; 70(3(May-Jun)): 660-677.
McCaffrey C: Major stressors and their effects on the wellbeing of children with cancer. J Pediatr Nurs. 2006; 21(1): 59-66.
Jessor R: Risk behavior in adolescence: A psychosocial framework for understanding and action. J Adolesc Health. 1991; 12(8): 597-605.
Kendler KS, Bulik CM, Silberg J, et al.: Childhood sexual abuse and adult psychiatric and substance use disorders in women: An epidemiological and cotwin control analysis. Arch Gen Psychiatry. 2000; 57(10): 953-959.
Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med. 2005; 6(6): 432-442.
Wasan AD, Butler SF, Budman SH, et al.: Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007; 23(4): 307-315.
Derogatis LR, Morrow GR, Fetting J, et al.: The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249(6): 751-757.
Wilsey BL, Fishman SM, Tsodikov A, et al.: Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008; 9(8): 1107-1117.
Martel MO, Wasan AD, Jamison RN, et al.: Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend. 2013; 132(1-2): 335-341.
Morasco BJ, Turk DC, Donovan DM, et al. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend. 2013; 127(1-3): 193-199.
Barth KS, Balliet W, Pelic CM, et al.: Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain. Pain Med. 2014; 15(8): 1359-1364.
Koyyalagunta D, Bruera E, Aigner C, et al.: Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med. 2013; 14(5): 667-675.
Boyd CJ, Young A, Grey M, et al.: Adolescents’ nonmedical use of prescription medications and other problem behaviors. J Adolesc Health. 2009; 45(6): 543-550.
Kessler R, Adler L, Barkley R, et al.: The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4): 716-723.
Roberts W, Peters J, Adams Z, et al.: Identifying the facets of impulsivity that explain the relation between ADHD symptoms and substance use in a nonclinical sample. Addict Behav. 2014; 39(8): 1272-1277.
Papaleontiou M, Henderson CR, Turner BJ, et al.: Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: A systematic review and meta-analysis. J Am Geriatr Soc. 2010; 58(7): 1353-1369.
Passik SD, Messina J, Golsorkhi A, et al.: Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage. 2011; 41(1): 116-125.
Reid MC, Engles-Horton LL, Weber MB, et al.: Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002; 17(3): 173-179.
Sullivan MD, Edlund MJ, Fan M-Y, et al.: Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: The TROUP Study. Pain. 2010; 150(2): 332-339.
Saroyan JM, Evans EA, Segoshi A, et al.: Interviewing and urine drug toxicology screening in a pediatric pain management center: An analysis of analgesic nonadherence and aberrant behaviors in adolescents and young adults. Clin J Pain. 2016; 32(1): 1-6.
Botvin G, Griffin K: School-based programs to prevent alcohol, tobacco and other drug use. Int Rev Psychiatry. 2008; 19(6): 607-615.
Cochran BN, Flentje A, Heck NC, et al.: Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014; 138: 202-208.
Fotiou A, Kanavou E, Richardson C, et al.: Misuse of prescription analgesics among adolescents in Greece: The importance of peer use and past prescriptions. Drugs. 2014; 21(5): 357-369.
Fischer B, Gittins J, Rehm J: Characterizing the “awakening elephant” of prescription opioid misuse in North America: Epidemiology, harms, interventions. Contemp Drug Probl. 2008; 35(2-3): 397-426.
Burgess F: Pain treatment, drug diversion, and the casualties of war. Pain Med. 2006; 7(6): 474-475.
Simoni-Wastila L, Tompkins C: Balancing diversion control and medical necessity: The case of prescription drugs with abuse potential. Subst Use Misuse. 2001; 36(9-10): 1275-1296.
Fishman SM, Papazian JS, Gonzalez S, et al.: Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Med. 2004; 5(3): 309-324.
Weissman MM, Johnson J: Drug use and abuse in five US communities. N Y State J Med. 1991; 91(11 suppl): 19S-23S.
Alford DP: Chronic back pain with possible prescription opioid misuse. JAMA. 2013; 309(9): 919-925.
Webster LR, Fine PG: Approaches to improve pain relief while minimizing opioid abuse liability. J Pain. 2010; 11(7): 602-611.
Butler SF, Budman SH, Fernandez KC, et al.: Cross-validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med. 2009; 3(2): 66-73.
Butler SF, Budman SH, Fernandez K, et al.: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004; 112(1-2): 65-75.
Butler SF, Fernandez K, Benoit C, et al.: Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008; 9(4): 360-372.
Butler SF, Budman SH, Fernandez KC, et al.: Development and validation of the current opioid misuse measure. Pain. 2007; 130(1-2): 144-156.
Passik SD, Kirsh KL: The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol. 2008; 16(5): 400-404.
Compton WM, Volkow ND: Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006; 81(2): 103-107.
Hofman SG, Asnaani A, Vonk IJJ, et al.: The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognit Ther Res. 2012; 36(5): 427-440.
Hofmann SG, Smits JAJ: Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008; 69(4): 621-632.
Spoth R, Trudeau L, Shin C, et al.: Longitudinal effects of universal preventive intervention on prescription drug misuse: Three randomized controlled trials with late adolescents and young adults. Am J Public Health. 2013; 103(4): 665-672.
Miaskowski C, Dodd MJ, West C, et al.: Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. J Clinical Oncol. 2001; 19(23): 4275-4279.
Manchikanti L, Singh A: Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008; 11(2 suppl): S63-S88.
Cone EJ, Caplan YH, Black DL, et al.: Urine drug testing of chronic pain patients: Licit and illicit drug patterns. J Anal Toxicol. 2008; 32(8): 530-543.
Owen GT, Burton AW, Schade CM, et al.: Urine drug testing: Current recommendations and best practices. Pain Physician. 2012; 15(3 suppl): ES119-ES133.
Levy S, Sherritt L, Vaughn B, et al.: Results of random drug testing in an adolescent substance abuse program. Pediatrics. 2007; 119(4): e843-e848.
Breitbart W, Rosenfeld B, Passik S, et al.: A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain. 1997; 72(1-2): 235-243.
Passik SD, Kirsh KL, Donaghy KB, et al.: Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006; 22(2): 173-181.
Pergolizzi JV, Gharibo C, Passik S, et al.: Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012; 72(6): 443-451.
Portenoy RK: Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996; 11(4): 203-217.
Weaver MF, Schnoll SH: Opioid treatment of chronic pain in patients with addiction. J Pain Palliat Care Pharmacother. 2002; 16(3): 5-26.
Ziegler PP: Addiction and the treatment of pain. Subst Use Misuse. 2005; 40(13-14): 1945-1954.
Lusher J, Elander J, Bevan D, et al.: Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain. 2006; 22(3): 316-324.
Weissman DE: Pseudoaddiction #69. J Palliat Med. 2005; 8(6): 1283-1284.
Published
How to Cite
Issue
Section
License
Copyright 2005-2024, Weston Medical Publishing, LLC
All Rights Reserved
